Cytokinetics, Incorporated (CYTK)

Cytokinetics Market Cap

Cytokinetics has a market cap or net worth of $11.74 billion as of July 2, 2026. Its market cap has increased by 202.17% in one year.

• Market Cap: 11.74B
• Enterprise Value: 12.37B
• 1-Year Change: 202.17%
• Ranking: #885
• Category: Large-Cap
• Stock Price: $86.49

Market Cap Chart

Since April 30, 2004, Cytokinetics's market cap has increased from $419.30M to $11.74B, an increase of 2,700.57%. That is a compound annual growth rate of 16.21%.

Market Cap History

Date	Market Cap	% Change
Jul 2, 2026	10.76B	38.53%
Dec 31, 2025	7.77B	39.94%
Dec 31, 2024	5.55B	-32.19%
Dec 29, 2023	8.19B	88.80%
Dec 30, 2022	4.34B	13.41%
Dec 31, 2021	3.82B	159.95%
Dec 31, 2020	1.47B	134.61%
Dec 31, 2019	626.90M	81.29%
Dec 31, 2018	345.80M	-21.27%
Dec 29, 2017	439.20M	-10.79%
Dec 30, 2016	492.30M	21.17%
Dec 31, 2015	406.30M	38.57%
Dec 31, 2014	293.20M	52.87%
Dec 31, 2013	191.80M	104.04%
Dec 31, 2012	94.00M	35.45%
Dec 30, 2011	69.40M	-49.60%
Dec 31, 2010	137.70M	-22.34%
Dec 31, 2009	177.30M	25.83%
Dec 31, 2008	140.90M	-39.40%
Dec 31, 2007	232.50M	-17.84%
Dec 29, 2006	283.00M	51.01%
Dec 30, 2005	187.40M	-35.49%
Dec 31, 2004	290.50M	-30.72%
Apr 30, 2004	419.30M	-

View and export this data all the way back to 2004. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jul 2, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Jul 3, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Exelixis	13.68B
Ionis Pharmaceuticals	13.10B
Axsome Therapeutics	12.60B
Madrigal Pharmaceuticals	12.38B
Arrowhead Pharmaceuticals	11.48B
Summit Therapeutics	11.31B
BioMarin Pharmaceutical	11.15B
Bio-Techne	11.01B